Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ikejiri

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nature|October 28, 1976
Direct estimation of frequency of cytotoxic T lymphocytes by a modified plaque assayB Bonavida, B Ikejiri, E Kedar
NIDA Research Monograph|January 1, 1987
Opiate receptor mediated regulation of the immune response in vivoR J Weber, B Ikejiri, K C Rice, et al.
Journal of Neurosurgery|March 1, 1989
Implantation of dispersed cells into primate brainR J Plunkett, S C Saris, K S Bankiewicz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1986
Human oncogene-transfected tumor cells display differential susceptibility to lysis by lymphokine-activated killer cells (LAK) and natural killer cellsL A Lanza, D J Wilson, B Ikejiri, et al.
International Journal of Oncology|May 14, 2011
Allelic deletions on chromosome-17 and mutations in the p53 gene in tumors metastatic to brainC Piccirilli, A Saxena, J Robertson, et al.
Journal of Neuro-Oncology|January 1, 1987
Lymphokine activated killer (LAK) cell mediated killing of human glioma: effect of pretreating glioma with various membrane modifying agentsS K Jacobs, C W Parham, B Holcomb, et al.
Cancer Research|December 1, 1992
Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomasA Saxena, W C Clark, J T Robertson, et al.
Cancer Research|January 1, 1994
Heterogeneity of subcellular localization of p53 protein in human glioblastomasI U Ali, J B Schweitzer, B Ikejiri, et al.
Journal of Neurosurgery|January 5, 2002
Site-specific immune response to implanted gliomasM A Proescholdt, M J Merrill, B Ikejiri, et al.
Journal of the National Cancer Institute|April 6, 1988
Morphology of interleukin-2-stimulated human peripheral blood mononuclear effector cells killing glioma-derived tumor cells in vitroG R Hook, M A Greenwood, D Barba, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nature|October 28, 1976
Direct estimation of frequency of cytotoxic T lymphocytes by a modified plaque assayB Bonavida, B Ikejiri, E Kedar
NIDA Research Monograph|January 1, 1987
Opiate receptor mediated regulation of the immune response in vivoR J Weber, B Ikejiri, K C Rice, et al.
Journal of Neurosurgery|March 1, 1989
Implantation of dispersed cells into primate brainR J Plunkett, S C Saris, K S Bankiewicz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1986
Human oncogene-transfected tumor cells display differential susceptibility to lysis by lymphokine-activated killer cells (LAK) and natural killer cellsL A Lanza, D J Wilson, B Ikejiri, et al.
International Journal of Oncology|May 14, 2011
Allelic deletions on chromosome-17 and mutations in the p53 gene in tumors metastatic to brainC Piccirilli, A Saxena, J Robertson, et al.
Journal of Neuro-Oncology|January 1, 1987
Lymphokine activated killer (LAK) cell mediated killing of human glioma: effect of pretreating glioma with various membrane modifying agentsS K Jacobs, C W Parham, B Holcomb, et al.
Cancer Research|December 1, 1992
Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomasA Saxena, W C Clark, J T Robertson, et al.
Cancer Research|January 1, 1994
Heterogeneity of subcellular localization of p53 protein in human glioblastomasI U Ali, J B Schweitzer, B Ikejiri, et al.
Journal of Neurosurgery|January 5, 2002
Site-specific immune response to implanted gliomasM A Proescholdt, M J Merrill, B Ikejiri, et al.
Journal of the National Cancer Institute|April 6, 1988
Morphology of interleukin-2-stimulated human peripheral blood mononuclear effector cells killing glioma-derived tumor cells in vitroG R Hook, M A Greenwood, D Barba, et al.
Pageof 2